DANIEL JENNINGS: Open Payments
NPI 1710596135 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 20 payments from 10 companies in 2025. Trend: 2023 $554 · 2024 $573 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $120 |
| Kestra Medical Technology Services, Inc. | 3 | $65 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| BridgeBio Pharma, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
| PFIZER INC. | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $12 |
Products named: Ozempic, Assure WCD, ELIQUIS, Attruby, Repatha, SAPIEN 3 Ultra RESILIA, Kerendia, Wegovy.
Industry payments across IN — which companies pay providers there.
